NYSE Arca submitted a proposed amendment to Rule 8.201-E to the SEC on April 27, naming XRP alongside Bitcoin, Ethereum, and Solana as eligible assets for commodity-based trust shares, in a legally reviewed filing that requires trusts to hold at least 85% of net asset value in qualifying digital assets.
NYSE XRP news landed on April 27 when NYSE Arca submitted a proposed amendment to Rule 8.201-E, the exchange’s generic listing framework for commodity-based trust shares, naming XRP as one of four digital assets eligible for commodity trust products under a new 85% portfolio concentration threshold. The SEC has since opened the proposal for public comment. The filing does not make a formal legal determination classifying XRP as a commodity. It identifies XRP as an example of an asset that could qualify because XRP-based futures contracts have traded on designated markets for more than six months and XRP is already associated with exchange-traded products providing significant market exposure.
As Yahoo Finance reported, the 85% threshold means a trust must hold at least 85% of its net asset value in assets that already satisfy NYSE Arca’s existing eligibility criteria, with up to 15% permitted in non-qualifying holdings. The filing gives a concrete example: a trust holding 95% across Bitcoin, Ethereum, Solana, and XRP would pass, while a trust holding Bitcoin alongside OTC call options on a Bitcoin ETF where the qualifying exposure falls to 71% would fail. Sponsors would be required to monitor the 85% threshold daily and notify NYSE Arca immediately upon falling out of compliance. The filing also explicitly excludes non-fungible assets and collectibles from the commodity definition, closing the generic listing route for those products. The SEC published the filing and invited public comment before issuing any final decision, with the outcome subject to the standard Securities Exchange Act review procedures. As crypto.news reported, XRP was already named as one of 16 digital commodities in the joint SEC and CFTC taxonomy issued on March 17, 2026, making the NYSE Arca filing consistent with and building on that prior regulatory classification rather than establishing a new one.
The significance of the filing is practical rather than definitional. NYSE Arca naming XRP explicitly in a generic listing standard submitted to the SEC is a legally reviewed institutional action, not analyst commentary. As crypto.news documented, the March 2026 joint SEC-CFTC classification of XRP as a digital commodity already placed it on the same regulatory footing as Bitcoin and Ethereum for purposes of exchange-traded product approvals and derivatives oversight, with Coinbase subsequently filing to launch Trade at Settlement for XRP futures on May 1 in direct response to that commodity status. The NYSE Arca amendment extends that framework by embedding XRP into the exchange’s generic listing standards for commodity trust products, which compresses the timeline for future XRP-linked trust product approvals to the same streamlined track that Bitcoin and Ethereum commodity trust products now use.
As crypto.news tracked, T. Rowe Price amended its Active Crypto ETF filing on April 29, naming XRP alongside Bitcoin, Ethereum, and Solana as potential holdings in a fund targeting an SEC-listed launch very soon, with Bloomberg ETF analyst Eric Balchunas describing the filing as having reached its third amendment with a launch “likely very soon.” The combination of the March 17 joint commodity taxonomy, the NYSE Arca Rule 8.201-E amendment, the Coinbase TAS futures launch, and the T. Rowe Price filing represents four separate institutional layers all treating XRP as a commodity-grade asset within a three-week window, each building on the prior action without any single event constituting a definitive Congressional classification under the CLARITY Act, which would convert the current regulatory treatment into permanent federal law.
The NYSE Arca proposal is under review by the SEC with public comment open. The filing’s formal effect on XRP’s commodity classification depends on whether the CLARITY Act passes in May, which would convert the current regulatory treatment into binding federal statute.
